FDA Approves Pertuzumab for Advanced, Her2+ Breast Cancer

My opinion is not quite formed on this new antibody. The FDA’s decision was based on results of one trial of 808 patients, half of whom didn’t get the experimental drug…

Posted in Breast Cancer, cancer treatment, Oncology (cancer), Pharmacology, ScienceTagged , , , , , , , , , Leave a Comment on FDA Approves Pertuzumab for Advanced, Her2+ Breast Cancer